Direction of Market Influences - Report Highlights Questcor Pharmaceuticals, Inc. and Perrigo Company
December 13, 2011 09:00 ET
Direction of Market Influences - Report Highlights Questcor Pharmaceuticals, Inc. and Perrigo Company
NEW YORK, NY--(Marketwire - Dec 13, 2011) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Questcor Pharmaceuticals, Inc. (
Upcoming macro-economic 'tides of influence' are buoyed by crisis both home and abroad. Spanish and Italian yields continue to climb as efforts by the European Central Bank have stopped short of establishing sovereign bond guarantees for any one country. The result is historic yields and a grave concern for the solvency of interbank lending. Markets were drawn to concerns over domestic policy stalemates producing downgrade risks. Despite the situation, there continues to be unique value and opportunity found within careful discretion.
Brighton Markets is releasing new coverage on Questcor Pharmaceuticals, Inc. for its current position within the healthcare industry. Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration (FDA). Acthar is approved for the treatment of 19 indications. The full research report on Questcor Pharmaceuticals, Inc. (
Brighton Markets has released research on Perrigo Company for its changing role within the healthcare industry. Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The full research report on Perrigo Company (
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.